PURPOSE: This study was conducted to evaluate the heterogeneity of studies estimating the association between risk factors (age, gender, and polypharmacy) and the use of potentially inappropriate drug therapy for the elderly (PIDT). METHODOLOGY: This study is a systematic review with meta-analysis of observational studies. LILACS, PubMed, Scopus, and the Web of Science databases were reviewed. The following data were extracted from the included studies: country, type of study, characteristics of the sample, practice scenarios, instruments to evaluate potentially inappropriate drug therapy for the older adults, and patient-related variables. RESULTS: Twenty-nine articles (17 cross-sectional and 12 cohort) were included. The majority of the studies were conducted in Europe. Regarding the study durations, 3 to 18 months was necessary to perform the research. As for the sample characteristics, all the studies analyzed involved the older adults and included anywhere from 96 patients to 33,830,599 outpatient consultations. Of the variables analyzed, only polypharmacy presented a positive association with the use of PIDT. All meta-analysis studies showed high heterogeneity, indicating the lack of a methodological standardization of the studies included, among other factors.
PURPOSE: This study was conducted to evaluate the heterogeneity of studies estimating the association between risk factors (age, gender, and polypharmacy) and the use of potentially inappropriate drug therapy for the elderly (PIDT). METHODOLOGY: This study is a systematic review with meta-analysis of observational studies. LILACS, PubMed, Scopus, and the Web of Science databases were reviewed. The following data were extracted from the included studies: country, type of study, characteristics of the sample, practice scenarios, instruments to evaluate potentially inappropriate drug therapy for the older adults, and patient-related variables. RESULTS: Twenty-nine articles (17 cross-sectional and 12 cohort) were included. The majority of the studies were conducted in Europe. Regarding the study durations, 3 to 18 months was necessary to perform the research. As for the sample characteristics, all the studies analyzed involved the older adults and included anywhere from 96 patients to 33,830,599 outpatient consultations. Of the variables analyzed, only polypharmacy presented a positive association with the use of PIDT. All meta-analysis studies showed high heterogeneity, indicating the lack of a methodological standardization of the studies included, among other factors.
Authors: Vittorio Maio; Christine W Hartmann; Sara Poston; Xinyue Liu-Chen; James Diamond; Christine Arenson Journal: Am J Med Qual Date: 2006 May-Jun Impact factor: 1.852
Authors: Iain M Carey; Stephen De Wilde; Tess Harris; Christina Victor; Nicky Richards; Sean R Hilton; Derek G Cook Journal: Drugs Aging Date: 2008 Impact factor: 3.923
Authors: Holly M Holmes; Ruili Luo; Yong-Fang Kuo; Jacques Baillargeon; James S Goodwin Journal: Pharmacoepidemiol Drug Saf Date: 2013-03-14 Impact factor: 2.890
Authors: Mary Jo V Pugh; Amy K Rosen; Maria Montez-Rath; Megan E Amuan; Benjamin G Fincke; Muriel Burk; Arlene Bierman; Francesca Cunningham; Eric M Mortensen; Dan R Berlowitz Journal: Med Care Date: 2008-02 Impact factor: 2.983
Authors: Christopher J Lane; Susan E Bronskill; Kathy Sykora; Irfan A Dhalla; Geoffrey M Anderson; Muhammad M Mamdani; Sudeep S Gill; Jerry H Gurwitz; Paula A Rochon Journal: J Am Geriatr Soc Date: 2004-06 Impact factor: 5.562
Authors: Dedan Opondo; Saied Eslami; Stefan Visscher; Sophia E de Rooij; Robert Verheij; Joke C Korevaar; Ameen Abu-Hanna Journal: PLoS One Date: 2012-08-22 Impact factor: 3.240
Authors: Maria Ukhanova; Sheila Markwardt; Jon P Furuno; Laura Davis; Brie N Noble; Ana R Quiñones Journal: J Am Geriatr Soc Date: 2021-05-06 Impact factor: 7.538
Authors: Steven G Morgan; Deirdre Weymann; Brandy Pratt; Kate Smolina; Emilie J Gladstone; Colette Raymond; Barbara Mintzes Journal: Age Ageing Date: 2016-05-05 Impact factor: 10.668